Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupoint hot compress with fennel kosher salt for intestinal adverse reactions of myeloablative chemotherapy
ChiCTR2400093323Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of palonosetron in hematopoietic malignancies, chemotherapy-induced nausea and vomiting (CINV) and gastrointestinal conditions (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Occurrence and severity of nausea and vomiting. Started Dec 2024; status: recruiting.
02
Drugs
palonosetron
03
Conditions
hematopoietic malignancieschemotherapy-induced nausea and vomiting (CINV)gastrointestinal conditions
Beyond the preview
Go deeper on ChiCTR2400093323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400093323.